Status:
UNKNOWN
Noninvasive Brain Stimulation Training
Lead Sponsor:
Neuromed IRCCS
Conditions:
Brain Injuries
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Non-invasive cerebral stimulation techniques have shown potential in the treatment of neurological disorders such as chronic pain, Parkinson's disease, neglect, aphasia, memory, engine deficit and epi...
Detailed Description
Introduction TMS is a non-invasive neuronal stimulation of surface areas of the brain that since its introduction in 1985 has been frequently used in neurology as a diagnostic and research tool. TMS u...
Eligibility Criteria
Inclusion
- The sample estimate was made by analogy after a literature analysis. Considering the risk of abandonment quite high, our intention is to recruit at least 100 subjects in a population of patients with cerebral injury who are involved in the neurological department of I.R.R.C.S. Neuromed by Pozzilli, featuring the symptoms described below in the inclusion criteria
- Inclusion criteria:
- Males or females aged between 18 and 80;
- Presence of: Disinfection, Multiple Sclerosis, Depression, Sensory Disorder or Neuropathic Pain;
- Female subjects can not be pregnant, can not breastfeed, have been born at least three months before the beginning of the study, undertake not to schedule a pregnancy for the duration of the study;
- Patients should be able to follow protocol guidelines throughout the study;
- Patients should be able to understand the aims and risks of the study;
- Signature of informed consent, approved by our Ethics Committee.
- Exclusion criteria:
- Tumors or systemic infections;
- Patients with impaired hepatic function (ALT\> 3 x Upper Limit Normal (ULN), Alkaline Phosphatase\> 2 x ULN, bilirubin tot\> 2 x ULN if associated with any increase in ALT or alkaline phosphatase); Severe or moderate renal failure;
- Patients with TMS or tDCS (pacemaker, intracerebral metal clip, epilepsy ...)
- Patients with other pathologies which, according to the scientific officer's opinion, prevent recruitment;
- Patients unable to even partially understand and want.
Exclusion
Key Trial Info
Start Date :
November 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03228472
Start Date
November 22 2017
End Date
December 31 2025
Last Update
October 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Neuromed
Pozzilli, Isernia, Italy, 86077